| Literature DB >> 2746023 |
M Wiranowska1, T C Wilson, K Thompson, L D Prockop.
Abstract
Systemically administered interferon (IFN) is not readily detected in the central nervous system (CNS) due to the presence of the blood-brain barrier (BBB). A method of osmotic BBB alteration in a mouse model was established in this laboratory. IFN's entry into the normal and osmotically altered brain after its intracarotid injection was investigated. Significant IFN levels (100-1,000 units) in the brain can be achieved by this method. The highest IFN activity was found in the brain hemisphere ipsilateral to the injection site within 20 min to 1 h after injection. IFN activity in the brain was detectable up to 4 h. Animals injected in this manner with murine IFN-alpha/beta (MuIFN-alpha/beta) and observed for a 6-month time interval showed no signs of neurological dysfunctions and resumed their normal activities. The therapeutic value of this method will be tested in a murine model of malignant glioma.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2746023 DOI: 10.1089/jir.1989.9.353
Source DB: PubMed Journal: J Interferon Res ISSN: 0197-8357